Cargando...
Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a...
Gardado en:
| Publicado en: | J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Singapore
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188775/ https://ncbi.nlm.nih.gov/pubmed/32185517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01680-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|